Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
1.903M
Cash
10.04M
Avg Qtr Burn
-4.234M
Short % of Float
3.72%
Insider Ownership
3.30%
Institutional Own.
2.82%
Qtr Updated
09/30/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
CTx-1301 Details Attention deficit hyperactivity disorder, Mental health | Phase 3 Update | |
CTx-1302 Details Mental health, Attention deficit hyperactivity disorder | Phase 1/2 Initiation | |
CTx-2103 (buspirone) Details Mental health, Anxiety Disorders | IND Submission |